China

Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
Fierce Biotech
Fri, 09/2/22 - 12:32 pm
Novo Nordisk
obesity
China
IPOs
Sorrento to begin Phase I trial of oral Covid-19 treatment
Clinical Trials Arena
Mon, 08/22/22 - 09:45 am
Sorrento Therapeutics
COVID-19
China
STI-1588
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
Fierce Biotech
Thu, 08/18/22 - 12:36 pm
Roche
Genentech
China
Jemincare
biobucks
prostate cancer
Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent
Fierce Biotech
Fri, 08/5/22 - 10:38 am
Sanofi
China
oncology
cancer
Innovent
Merck's ADC hunt continues with second deal for China biotech Kelun
Endpoints
Tue, 07/26/22 - 05:24 pm
Merck
antibody-drug conjugate
solid tumors
China
Kelun Biotech
Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks
Endpoints
Mon, 07/25/22 - 10:37 am
siRNA
China
Sanofi
Rona Therapeutics
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
Wed, 07/13/22 - 10:03 am
China
drug pricing
price cuts
AstraZeneca
Pfizer
Novartis
generics
VC dollars keep rolling in as Qiming ties a ribbon on $2.5B Fund VIII
Endpoints
Mon, 07/11/22 - 10:23 am
venture capital
Qiming Ventures
funding
China
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
Tue, 07/5/22 - 11:52 pm
China
biotech
WuXi Biologics
Boehringer Ingelheim
Siemens Healthineers
AstraZeneca
Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma
Endpoints
Mon, 06/27/22 - 06:58 pm
Amgen
China
Fosun Pharmaceutical
AstraZeneca continues to build out its presence in China with new COPD drug manufacturing site
Endpoints
Wed, 06/22/22 - 06:55 pm
AstraZeneca
China
COPD
drug manufacturing
Merck snaps up cancer drug from China’s Kelun in $1.4bn deal
Pharmaforum
Wed, 05/18/22 - 11:53 pm
Merck
immuno-oncology
China
Sichuan Kelun Pharmaceutical
Merck KGaA warns of volatile 2022 thanks to war in Ukraine and fresh COVID lockdowns in China
Fierce Pharma
Thu, 05/12/22 - 10:49 am
Merck KGaA
Ukraine
Russia
China
COVID-19
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in conviction
Fierce Pharma
Tue, 05/3/22 - 10:39 am
GSK
trade secrets
DOJ
China
Quiet CDMO makes noise, throwing down $500M for manufacturing campus and moving forward with China operations
Endpoints
Tue, 04/12/22 - 08:37 pm
VectorBuilder
CDMOs
China
chicago
drug manufacturing
Biden likely to sign a bill that would crack down on China's chokehold on the antibiotic supply
Endpoints
Wed, 03/30/22 - 10:59 am
Senate
legislation
China
antibiotics
Joe Biden
Another strike for biotech: China
EP Vantage
Mon, 03/14/22 - 10:18 am
biotech
China
foreign inspections
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Fierce Biotech
Thu, 02/17/22 - 10:56 am
Innovent Biologics
China
clinical trials
Amgen
Sanofi
FDA sends signal with tough questions of Lilly at cancer drug meeting
BioPharma Dive
Thu, 02/10/22 - 10:37 pm
Eli Lilly
Innovent Biologics
lung cancer
clinical trials
China
China-Developed Drugs for U.S. Market Could Face Steep Hill
BioSpace
Wed, 02/9/22 - 11:01 am
China
drug approvals
FDA
clinical trials

Pages